Skip to main content
SpringerLink
Log in

CD5-negative mantle cell lymphoma shows a less aggressive outcome and variable SOX11 staining

  • Original Article
  • Published:
Journal of Hematopathology Aims and scope Submit manuscript

Abstract

Mantle cell lymphoma (MCL) is an uncommon B-cell lymphoma that prototypically expresses CD5, but a small subset is CD5 negative. The clinical significance of CD5 negativity is not yet well-elucidated. This case series aims to contribute to the understanding of CD5-negative MCL by looking at specific markers and outcome in our cases with long-term follow-up. Eight cases of CD5-negative MCL were identified in the case files at the Massachusetts General Hospital from 1978 to 2016. Clinicopathological characteristics were evaluated, including immunohistochemical stains for cyclin D1, SOX11, Ki67, and p53. Patients initially presented with involvement of lymph nodes and spleen (n = 4), sinonasal or oral mucosa (n = 2), orbital soft tissue (n = 1), and salivary gland (n = 1). On histology, the cases all showed classic MCL morphology, with a monotonous population of medium-sized cells with irregular nuclear contours. The cases were positive by immunohistochemistry for cyclinD1 (8/8 cases), essentially negative for p53 staining (8/8 cases), and mostly positive for SOX11 (5/8 cases). All cases had a low Ki67 proliferation rate (<5%). Long-term clinical follow-up on five cases showed that four patients had a clinical course complicated by multiple relapses to the skin, soft tissue, liver, and bone marrow. Seven cases with available follow-up showed an average survival of 121 months (SD 86 months), with no detectable survival difference between the SOX11 positive and negative cases. CD5-negative MCL is an uncommon subtype of MCL that overall appears to have a better prognosis and longer overall survival than classic MCL, despite SOX11 expression. The cases also show little p53 expression and a low Ki67 proliferation index.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Swerdlow SH (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon

    Google Scholar 

  2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390. doi:10.1182/blood-2016-01-643569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Avet-Loiseau H, Garand R, Gaillard F, Daviet A, Mellerin MP, Robillard N, Bouyge I, Arcot S, Batzer M, Talmant P, Harousseau JL, Milpied N, Bataille R (1998) Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes Cancer 23(2):175–182. doi:10.1002/(SICI)1098-2264(199810)23:2%3C175::AID-GCC11%3E3.0.CO;2-N

    Article  CAS  PubMed  Google Scholar 

  4. Li JY, Gaillard F, Moreau A, Harousseau JL, Laboisse C, Milpied N, Bataille R, Avet-Loiseau H (1999) Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol 154(5):1449–1452. doi:10.1016/S0002-9440(10)65399-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Abrahamsson A, Albertsson-Lindblad A, Brown PN, Baumgartner-Wennerholm S, Pedersen LM, D’Amore F, Nilsson-Ehle H, Jensen P, Pedersen M, Geisler CH, Jerkeman M (2014) Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study. Blood 124(8):1288–1295. doi:10.1182/blood-2014-03-559930

    Article  CAS  PubMed  Google Scholar 

  6. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, Sargent RL, Espinet B, Climent F, Jacobs SA, Delabie J, Naresh KN, Bagg A, Brousset P, Warnke RA, Serrano S, Harris NL, Swerdlow SH, Jaffe ES, Campo E (2012) In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica 97(2):270–278. doi:10.3324/haematol.2011.052621

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hsi ED, Martin P (2014) Indolent mantle cell lymphoma. Leuk Lymphoma 55(4):761–767. doi:10.3109/10428194.2013.815353

    Article  PubMed  Google Scholar 

  8. Martin P, Chadburn A, Christos P, Weil K, Furman RR, Ruan J, Elstrom R, Niesvizky R, Ely S, Diliberto M, Melnick A, Knowles DM, Chen-Kiang S, Coleman M, Leonard JP (2009) Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol 27(8):1209–1213. doi:10.1200/JCO.2008.19.6121

    Article  PubMed  Google Scholar 

  9. Ondrejka SL, Lai R, Smith SD, Hsi ED (2011) Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 96(8):1121–1127. doi:10.3324/haematol.2010.036277

    Article  PubMed  PubMed Central  Google Scholar 

  10. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, Catovsky D, Thomas PW, Avet-Loiseau H, Oscier D (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101(12):4975–4981. doi:10.1182/blood-2002-06-1864

    Article  CAS  PubMed  Google Scholar 

  11. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, Pfreundschuh M, Reiser M, Metzner B, Einsele H, Peter N, Jung W, Wormann B, Ludwig WD, Duhrsen U, Eimermacher H, Wandt H, Hasford J, Hiddemann W, Unterhalt M (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111(2):558–565. doi:10.1182/blood-2007-06-095331

    Article  CAS  PubMed  Google Scholar 

  12. Hoster E, Klapper W, Hermine O, Kluin-Nelemans HC, Walewski J, van Hoof A, Trneny M, Geisler CH, Di Raimondo F, Szymczyk M, Stilgenbauer S, Thieblemont C, Hallek M, Forstpointner R, Pott C, Ribrag V, Doorduijn J, Hiddemann W, Dreyling MH, Unterhalt M (2014) Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the European mantle-cell lymphoma Network. J Clin Oncol 32(13):1338–1346. doi:10.1200/JCO.2013.52.2466

    Article  PubMed  Google Scholar 

  13. Hoster E, Rosenwald A, Berger F, Bernd HW, Hartmann S, Loddenkemper C, Barth TF, Brousse N, Pileri S, Rymkiewicz G, Kodet R, Stilgenbauer S, Forstpointner R, Thieblemont C, Hallek M, Coiffier B, Vehling-Kaiser U, Bouabdallah R, Kanz L, Pfreundschuh M, Schmidt C, Ribrag V, Hiddemann W, Unterhalt M, Kluin-Nelemans JC, Hermine O, Dreyling MH, Klapper W (2016) Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European mantle cell lymphoma Network. J Clin Oncol 34(12):1386–1394. doi:10.1200/JCO.2015.63.8387

    Article  CAS  PubMed  Google Scholar 

  14. Halldorsdottir AM, Lundin A, Murray F, Mansouri L, Knuutila S, Sundstrom C, Laurell A, Ehrencrona H, Sander B, Rosenquist R (2011) Impact of TP53 mutation and 17p deletion in mantle cell lymphoma. Leukemia 25(12):1904–1908. doi:10.1038/leu.2011.162

    Article  CAS  PubMed  Google Scholar 

  15. Nygren L, Baumgartner Wennerholm S, Klimkowska M, Christensson B, Kimby E, Sander B (2012) Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 119(18):4215–4223. doi:10.1182/blood-2011-12-400580

    Article  CAS  PubMed  Google Scholar 

  16. Slotta-Huspenina J, Koch I, de Leval L, Keller G, Klier M, Bink K, Kremer M, Raffeld M, Fend F, Quintanilla-Martinez L (2012) The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index. Haematologica 97(9):1422–1430. doi:10.3324/haematol.2011.055715

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, Pedrinis E, Feller AC, Merz H, Janssen D, Hansmann ML, Krieken H, Moller P, Stein H, Unterhalt M, Hiddemann W, Parwaresch R (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131(1):29–38. doi:10.1111/j.1365-2141.2005.05716.x

    Article  PubMed  Google Scholar 

  18. Shapiro JL, Miller ML, Pohlman B, Mascha E, Fishleder AJ (1999) CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients. Am J Clin Pathol 111(4):477–487

    Article  CAS  PubMed  Google Scholar 

  19. Zapata M, Budnick SD, Bordoni R, Li S (2010) An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma. Int J Clin Exp Pathol 3(4):430–436

    PubMed  PubMed Central  Google Scholar 

  20. Yoo SB, Kim YA, Jeon YK, Kim CW (2008) CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report. Pathol res Pract 204(10):779–783. doi:10.1016/j.prp.2008.04.009

    Article  PubMed  Google Scholar 

  21. Liu Z, Dong HY, Gorczyca W, Tsang P, Cohen P, Stephenson CF, Berger CS, Wu CD, Weisberger J (2002) CD5- mantle cell lymphoma. Am J Clin Pathol 118(2):216–224. doi:10.1309/TE56-A43X-29TT-5H8G

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Massachusetts General Hospital, 55 Fruit St, Warren 2, Boston, MA, 02114, USA

    Angela R. Shih, Jacob R. Bledsoe, Penny McKelvie, Abner Louissaint, Nancy L. Harris & Lawrence Zukerberg

Authors
  1. Angela R. Shih
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacob R. Bledsoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Penny McKelvie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Abner Louissaint
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nancy L. Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lawrence Zukerberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angela R. Shih.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shih, A.R., Bledsoe, J.R., McKelvie, P. et al. CD5-negative mantle cell lymphoma shows a less aggressive outcome and variable SOX11 staining. J Hematopathol 10, 49–53 (2017). https://doi.org/10.1007/s12308-017-0292-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12308-017-0292-0

Keywords

Search

Navigation